EUVIMEDEUVIMED entdecken
Crossref

HIV-1 and Vaccine: Analysis of gp41 Target Sequences

Salvatore Dimonte, Rossana Scutari, Romina Salpini, Stefano Aquaro, Valentina Svicher, Michele Pellegrino

Current Microbiology · 2026

DOI: 10.1007/s00284-026-04936-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Microbiology, 2026. Verfasst von Salvatore Dimonte und 5 weiteren Autor:innen. Beteiligte Einrichtung: BioMolecular Lab, Laboratory Analysis, Via Mercadante 26, 76121, Barletta, Italy. salvatore.dimonte@gmail.com. Hauptthemen laut MEDLINE: AIDS Vaccines, HIV Antibodies, HIV Envelope Protein gp41, HIV Infections. Die Arbeit nennt 30 Literaturangaben. Gefördert von: PRIN from MIUR, Italy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite extensive efforts by scientists, academic institutions, and pharmaceutical companies, a safe and effective HIV/AIDS vaccine remains elusive. Most HIV-1 envelope peptide vaccine strategies have concentrated on Gp120, gp140, or gp160. HIV-1 Env trimer binding to the CD4-receptor initiates structural changes promoting the envelope's transition from a closed to an open state via an intermediate step. Broadly neutralizing antibodies target the state-1 Env conformation, while less effective antibodies typically recognize open states. However, due to virus variability, an optimal vaccine has not yet been successfully developed. In this study, focusing on the pivotal role of Gp41 in various vaccine strategies, a very large sequence dataset was utilized. These sequences were obtained from drug-naïve individuals or those undergoing antiretroviral therapy (ART). Gp41 amino acid variability was characterized genetically using a starting pool dataset of 24,505 full-length Env sequences from HIV-1 Subtype-B infected individuals. The dataset underwent hydropathy analysis, genetic distance evaluation, non-synonymous/synonymous substitution rate estimation, Shannon-Entropy calculation, and N-linked glycosylation (NLG) analysis. Similar variability between viral sequences retrieved from drug-naïve and antiretroviral-treated individuals was observed. In our dataset, ART selection pressures observed at gp41 level are minimal: 7 positions with dN/dS > 1, significant increases in entropy values, and a comparable value of glycosylation sites were highlighted. This study reinforces the importance of identifying specific single sensitizing mutations in HIV control. Gp41 remains an important vaccine target for understanding virus-host immunological interactions. Further analyses may reveal specific mechanisms related to host antiviral responses and viral regions with strong masking activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AIDS VaccinesHIV AntibodiesHIV Envelope Protein gp41HIV InfectionsHIV-1HumansAmino Acid SequenceAnti-Retroviral AgentsAntibodies, NeutralizingDatasets as TopicGlycosylation

Substanzen

AIDS VaccinesAnti-Retroviral AgentsAntibodies, Neutralizinggp41 protein, Human immunodeficiency virus 1HIV AntibodiesHIV Envelope Protein gp41

Autor:innen und Institutionen

  • BioMolecular Lab, Laboratory Analysis, Via Mercadante 26, 76121, Barletta, Italy. salvatore.dimonte@gmail.com.
  • Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
  • Multimodal Research Area, Unit of Microbiology and Diagnostics in Immunology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
  • Department of Biology, Tor Vergata University, Rome, Italy.
  • Department of Life, Health and Environmental Sciences, University of L'Aquila, Piazzale Salvatore Tommasi, 1, Blocco 11, Coppito, 67010, L'Aquila, Italy.
  • Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Rende, Italy.

Förderung

  • PRIN from MIUR, Italy

Zitieren

APA

Dimonte, S., Scutari, R., Salpini, R., Aquaro, S., Svicher, V., & Pellegrino, M. (2026). HIV-1 and Vaccine: Analysis of gp41 Target Sequences. Current Microbiology. https://doi.org/10.1007/s00284-026-04936-9

Vancouver

Dimonte S, Scutari R, Salpini R, Aquaro S, Svicher V, Pellegrino M. HIV-1 and Vaccine: Analysis of gp41 Target Sequences. Current Microbiology. 2026. doi:10.1007/s00284-026-04936-9

BibTeX
@article{Dimonte2026,
  author = {Dimonte, Salvatore and Scutari, Rossana and Salpini, Romina and Aquaro, Stefano and Svicher, Valentina and Pellegrino, Michele},
  title = {HIV-1 and Vaccine: Analysis of gp41 Target Sequences},
  journal = {Current Microbiology},
  year = {2026},
  doi = {10.1007/s00284-026-04936-9}
}
Kostenlos starten →